{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Janux Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"JANX"},"Address":{"label":"Address","value":"11099 N. TORREY PINES ROAD,SUITE 290 SUITE 200, LA JOLLA, California, 92037, United States"},"Phone":{"label":"Phone","value":"+1 858 750-4700"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer."},"CompanyUrl":{"label":"Company Url","value":"https://www.januxrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Charles Winter","title":"Chief Technical Officer"},{"name":"David Campbell","title":"President, Chief Executive Officer & Director"},{"name":"Jenna Daly","title":"Executive Director-Clinical Operations"},{"name":"Thomas DiRaimondo","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}